Longitudinal Evolution of Biomarkers of Dysautonomia and Inflammation During Sepsis in Children
Longitudinal Evolution of Biomarkers of Dysautonomia and Inflammation During Sepsis in Children - An Observational Study
Centre Hospitalier Universitaire de Saint Etienne
60 participants
Mar 29, 2023
OBSERVATIONAL
Conditions
Summary
The Autonomic Nervous System (ANS) regulates the inflammatory response in real time, just as it controls heart rate and other vital functions. Many studies have investigated induced stimulation of the vagus nerve and its therapeutic effect in inhibiting TNFα (Tumor Necrosis Factor alpha) secretion, and therefore the risk of hypotension, septic shock, organ dysfunction during inflammation. While the anti-inflammatory effect of the autonomic nervous system on inflammation has been well studied, conversely, the effect of major inflammation on the balance of the autonomic nervous system is more difficult to understand. The inflammatory reflex could be overwhelmed and the regulatory centers of the brainstem dysregulated during situations of extreme inflammation.
Eligibility
Inclusion Criteria7
- Hospitalization in a pediatric intensive care unit.
- Presenting the sepsis criteria
- Patient affiliated or entitled to a social security scheme
- Holders of parental authority having received informed information about the study and having signed the consent form
- Taking treatments that can alter the ANS (β-blockers, etc.) or inflammation (NSAIDs, corticosteroids)
- Patient affiliated or entitled to a social security scheme
- Holders of parental authority having received informed information about the study and having signed the consent form
Exclusion Criteria6
- Parents or legal guardians who do not speak French
- Chronic or acute pathology that can alter autonomic balance (congenital heart disease, encephalopathy, neuropathy, acute pain, etc.)
- Parents or legal guardians who do not speak French
- Chronic or acute pathology that can alter autonomic balance (congenital heart disease, encephalopathy, neuropathy, acute pain, etc.)
- Recent general anesthesia less than 1 month.
- Taking treatments that can alter the ANS (β-blockers, etc.) or inflammation (NSAIDs, corticosteroids)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
24h ECG monitoring
The usual biological tests necessary for the management of the child and the addition of 1 tube of 2 ml
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05807555